Login / Signup

A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody".

Haruka KoizumiYoshinao MuroSatoko ImaiYuta YamashitaMariko Ogawa-MomoharaTakuya TakeichiMegumi MurakamiTeruyuki MitsumaMasashi Akiyama
Published in: The Journal of dermatology (2022)
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • transcription factor
  • disease activity
  • rheumatoid arthritis
  • high glucose
  • oxidative stress
  • epidermal growth factor receptor